Patient and technique survival on CAPD in Turkey.
OBJECTIVE
To analyze the status of continuous ambulatory peritoneal dialysis (CAPD) in 12 centers in Turkey.


METHODS
Retrospective study of CAPD technique and patient outcome.


METHODS
University hospital renal units.


METHODS
334 patients [205 males (61%),129 (39%) females; mean age 42.2 +/- 13.8 years; mean follow-up time 23.5 +/- 18.3 months] beginning CAPD between March 1992 and December 1999, and having a minimum follow-up of 3 months.


METHODS
Patient survival, technique survival, and duration of hospitalization.


RESULTS
Mean weekly Kt/V urea was 1.9 +/- 0.8, weekly creatinine clearance was 62.9 +/- 8.5 L/1.73 m2, and mean serum albumin level was 3.7 +/- 0.6 g/dL. 93 patients (28%) were withdrawn from peritoneal dialysis due to death (12.6%), transplantation (3.9%), transfer to hemodialysis (8.7%), patient failure to adapt (1.5%), and other reasons (1.2%). The major causes of death were cardiovascular disease (60%), infection (19%), malignancy (2%), and others (19%). Cox proportional hazard model analysis indicated age, serum albumin levels, comorbidity, and functional status affected survival and hospitalization (p < 0.05), whereas gender and Kt/V did not (p > 0.05). Estimation of patient survival by Kaplan-Meier analysis showed 94.2%, 88.6%, 84.5%, and 68.9% at 1, 2, 3, and 5 years respectively. Technique survival estimate by Kaplan-Meier analysis was 96.6%, 91.1%, 90.4%, and 77.4% at 1, 2, 3, and 5 years respectively.


CONCLUSIONS
Peritoneal dialysis is an acceptable method of renal replacement therapy in Turkey. There is controversy regarding the usefulness of Kt/V in predicting mortality and morbidity.
Utaş
C
C
Nefroloji Bilim Dali, Erciyes Universitesi Tip Fakuiltesi, Kayseri Turkey. utas@erciyes.edu.tr
D000328:Adult; D005260:Female; D006760:Hospitalization; D006801:Humans; D007676:Kidney Failure, Chronic / Q000401:mortality / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects / Q000401:mortality / Q000592:standards; D012189:Retrospective Studies; D016019:Survival Analysis; D017211:Treatment Failure; D014421:Turkey / Q000453:epidemiology